PTC Therapeutics Executive Divests $2.25M in Stock via Pre-Arranged Plan
Neil Almstead, Chief Technical Operations Officer at PTC Therapeutics, Inc. (NASDAQ:PTCT), executed a series of stock transactions in late June 2026, selling 26,283 shares for approximately $2.25 million. These sales were part of a pre-arranged Rule 10b5-1 trading plan adopted in November 2025. The transactions occurred against a backdrop of signif…